Genmab — April 2020
-
Halozyme Announces Janssen Submits New Drug Application In Japan For Daratumumab Subcutaneous Formulation Utilizing Halozyme's ENHANZE
Technology For Patients With Multiple Myeloma https://www.halozyme.com/investors/news-releases/news-release-details/2020/Halozyme-Announces-Janssen-Submits-New-Drug-Application-In-Japan-For-Daratumumab-Subcutaneous-Formulation-Utilizing-Halozymes-ENHANZE-Technology-For-Patients-With-Multiple-Myeloma/default.aspx -
ADC THERAPEUTICS FILES REGISTRATION STATEMENT FOR PROPOSED INITIAL PUBLIC OFFERING https://adctherapeutics.com/press_release/adc-therapeutics-announces-first-patient-dosed-in-phase-i-clinical-trial-of-adct-402-loncastuximab-tesirine-and-ibrutinib-in-patients-with-advanced-diffuse-large-b-cell-lymphoma-or-mantle-cell-lymp-12/
-
-
Lidt læsestof til pensionisten. Ved ikke om det har været linket før ?
https://ir.genmab.com/static-files/50feecc4-912d-4dea-be45-5336fb10788c -
Der var flere pharma aktier som faldt tilbage i eftermiddag.
-
Genmab har en ny fan https://twitter.com/VincentRK/status/1254810548996366337?s=20
-
Jeffrey Cohen, MD: The Success of Ofatumumab in Relapsing MS https://www.youtube.com/watch?v=3hz6GX3lUKk
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind